Evogene Ltd
EVGN1.293USD
0.0000.00%
Fechamento 08/28, 16:00（ET）Cotações atrasadas em 15 min
11.27MValor de mercado
PerdaP/L TTM
Mais detalhes de Evogene Ltd Empresa
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Informações da empresa
Código da empresaEVGN
Nome da EmpresaEvogene Ltd
Data de listagemJun 11, 2007
CEODr. Arnon Heyman
Número de funcionários117
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 11
Endereço13 Gad Feinstein Street
CidadeREHOVOT
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísIsrael
Código postal7638517
Telefone97289311900
Sitehttps://evogene.com/
Código da empresaEVGN
Data de listagemJun 11, 2007
CEODr. Arnon Heyman
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Kenny Green
Kenny Green
Investor Relations
Investor Relations
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dan Michael Falk
Mr. Dan Michael Falk
Independent Director
Independent Director
--
--
Dr. Brian Ember
Dr. Brian Ember
Chief Executive Officer of AgPlenus Limited
Chief Executive Officer of AgPlenus Limited
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2024
FY2018
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: ter, 19 de ago
Atualizado em: ter, 19 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Recanati (Leon Yehuda)
0.96%
Virtu Americas LLC
0.37%
Citadel Advisors LLC
0.25%
Two Sigma Investments, LP
0.24%
Morgan Stanley & Co. LLC
0.17%
Outro
98.01%
Investidores
Investidores
Proporção
Recanati (Leon Yehuda)
0.96%
Virtu Americas LLC
0.37%
Citadel Advisors LLC
0.25%
Two Sigma Investments, LP
0.24%
Morgan Stanley & Co. LLC
0.17%
Outro
98.01%
Tipos de investidores
Investidores
Proporção
Individual Investor
0.96%
Research Firm
0.92%
Hedge Fund
0.49%
Investment Advisor
0.21%
Investment Advisor/Hedge Fund
0.05%
Outro
97.37%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
54
520.27K
5.97%
-411.44K
2025Q1
55
520.29K
6.01%
-409.22K
2024Q4
56
495.82K
9.24%
-272.31K
2024Q3
56
646.41K
12.68%
+45.84K
2024Q2
57
498.30K
80.86%
-140.56K
2024Q1
62
510.64K
10.05%
-122.17K
2023Q4
69
544.86K
11.19%
-474.65K
2023Q3
76
590.60K
14.30%
-53.35K
2023Q2
75
185.66K
4.46%
-461.57K
2023Q1
80
194.62K
4.68%
-499.69K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Recanati (Leon Yehuda)
83.89K
0.96%
--
--
Mar 17, 2025
Two Sigma Investments, LP
13.56K
0.16%
+2.40K
+21.53%
Mar 31, 2025
Morgan Stanley & Co. LLC
14.56K
0.17%
--
--
Mar 31, 2025
Jane Street Capital, L.L.C.
33.73K
0.39%
+12.39K
+58.03%
Mar 31, 2025
BNP Paribas Securities Corp. North America
12.82K
0.15%
--
--
Mar 31, 2025
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.11%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
18.75K
0.22%
-3.27K
-14.84%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.20K
0.05%
--
--
May 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Data
Tipo
Proporção
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
